MedWatch

Demant to release quarterly figures from May onwards

In order to become more transparent, hearing aid giant Demant will soon release revenue figures on a quarterly basis.

Photo: Demant / PR

Demant is making it easier to get an overview of the firm’s key figures.

In a stock exchange notification, the company has announced that it will be giving investors and interested parties a more detailed overview of the group’s different business areas and segments, starting with the next quarterly report.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs